All USA & Canada articles – Page 91
-
News
Common wristbands are hotbed for harmful bacteria
A new study tested various textures of wristbands and their ability to harbour harmful pathogenic bacteria.
-
News
Racial and ethnic differences in gut microbiome emerge at 3 months old
Gut microbiome variation associated with race and ethnicity arises after three months of age and persists through childhood, according to a new study.
-
News
Common cold virus exposure may help usher in immunity to Covid
Exposure to common cold-causing coronaviruses may contribute to pre-existing immunity to COVID-19, according to a new study.
-
News
Tubing and swimming change the chemistry and microbiome of streams
Scientists have reported preliminary results showing that tubing and swimming can alter the chemical and microbial fingerprint of streams, but the environmental and health ramifications are not yet known.
-
News
Gut microbiome can increase risk and severity of HIV and EBV disease
Researchers have shown that the microbiome has a significant impact on the acquisition of Epstein-Barr virus (EBV) and human immunodeficiency virus-1 (HIV) infection and plays a role in the course of disease.
-
News
Scientists reveal inner workings of Ebola’s ‘viral factories’
A new study reveals how the Ebola virus’s replication machinery forms fascinating microscopic structures inside host cells that become viral factories.
-
News
Academic-private partnership aims to reduce toxic effects of deadly C. diff
The Center for One Health Research and Nectagen Inc. have received a nearly $275,000 grant to study whether synthetic proteins developed by Nectagen can reduce the toxicity of the digestive bacterium.
-
News
Some phytoplankton can blitz neurotoxin methylmercury - even in the dark
In the search for ways to fight methylmercury in global waterways, scientists have discovered that some forms of phytoplankton are good at degrading the potent neurotoxin - even in the absence of sunlight.
-
News
Molnupiravir dose of human effect size-equivalent blocks Covid transmission in ferrets
Two oral drugs provide equivalent therapeutic benefit in preventing severe COVID-19 in animal models, but only molnupiravir efficiently blocked SARS-CoV-2 transmission when administered at a human effect size-equivalent dose.
-
News
Synthetic antibiotic could be effective against drug-resistant superbugs
Researchers have found a new antibiotic strategy to defeat gram-negative bacteria like Salmonella, Pseudomonas and E. coli, making use of a synthetic molecule that works fast and is durable in animal tests.
-
News
Engineered probiotic developed to treat multiple sclerosis
Researchers are working on a new approach to target autoimmunity in the brain, leveraging designer bacteria to make treatment safer and more effective.
-
News
Modulating type 1 Interferon may expand treatment options for COVID-19
Researchers have, for the first time in nonhuman primates, studied how modulating the signaling of type 1 Interferon (IFN-I), one of the body’s initial defenses against infection, impacts SARS-CoV-2 viral replication and disease progression.
-
News
Researchers find chink in the armour of tuberculosis pathogen
Discovery of drug resistance network could clear way for developing a drug to prevent pathogen from resisting and tolerating tuberculosis treatment.
-
News
AMR poses threat in all 35 countries in the Americas
569,000 deaths were linked to bacterial antimicrobial resistance in all 35 countries of the WHO Region of the Americas, according to a new study.
-
News
Egyptian cotton gene grants powerful resistance to resurging blight
An overlooked gene found in Egyptian cotton confers powerful resistance to bacterial blight, a plant disease that is threatening cotton production worldwide.
-
News
Flu deaths rise when pro sports teams move into cities
West Virginia University economists, whose research shows flu deaths increase when a city becomes home to a new professional sports team, say their data should make even the biggest fans reconsider support for taxpayer-funded stadium subsidies.
-
News
Current estimates of Lake Erie algae toxicity may miss the mark
A new study of the annual harmful algal bloom (HAB) in Lake Erie suggests that the toxicity of the bloom may be overestimated in earlier warm months and underestimated later in the summer.
-
News
Monoclonal antibody shows promise for treating chronic hepatitis B and D infections
In a preclinical study, the potential of an engineered investigational human monoclonal antibody for the treatment of chronic hepatitis B and hepatitis D has been demonstrated.
-
News
Researchers using synthetic microbiomes to protect aquatic communities from bacteria
Scientists have been awarded a grant to create synthetic microbiomes – communities of microorganisms – that will better protect aquatic environments from bacteria.
-
News
Changes in gut microbiome alters rewarding effects of cocaine and cravings
Scientists have provided the first evidence that changes in the gut microbiome have significant effects on cocaine use and cravings after withdrawal.